Theodore C Bania - Emergency Medicine | Mount Sinai

Biography

Specialties

Emergency Medicine

Research

AIDS/HIV, Addiction, Biodefense, Cardiovascular

As one of the pioneers in the development of Lipid Resuscitation Therapy for drug induced toxicity, Dr. Bania is interested in evaluating and developing other uses of lipids in drug toxicity. He is interested in the mechanism of action of Lipid Resuscitation and evaluating its use in a variety of toxins. Dr. Bania is also interested in research into the treatment of cardiovascular drug toxicity, chemical warfare agents and various recreational drugs. In addition, his research interest include the use of portable mobile devise to educate ED patients about HIV and encourage testing.

Education

MD, SUNY Downstate Health Sciences University - College of Medicine

Internship, Emergency Medicine, Metropolitan Hospital Center

Residency, Emergency Medicine, Metropolitan Hospital Center

Fellowship, Medical Toxicology, Mount Sinai Hospital

Certifications

American Board of Emergency Medicine

Honors & Awards

2010

Super Doctor

Publications

38

Publications

Selected Publications

The 2021 Core Content of Medical Toxicology. Robert G. Hendrickson, Theodore C. Bania, Carl R. Baum, Michael I. Greenberg, Kevin B. Joldersma, Julia N. Keehbauch. Journal of Medical Toxicology

Low rates of thiamine prescribing in adult patients with alcohol-related diagnoses in the emergency department. Nathan M. Peck, Theodore C. Bania, Jason Chu. American Journal of Drug and Alcohol Abuse

Computer-Based Substance Use Reporting and Acceptance of HIV Testing Among Emergency Department Patients. I. D. Aronson, C. M. Cleland, S. Rajan, L. A. Marsch, T. C. Bania. AIDS and Behavior

View All Publications

Office Locations

1000 10th Ave Rm GE 01

New York, NY 10019

212-523-3981

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Bania during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

State of New York, Office of the Attorney General,
Vigorito, Barker, Patterson, Nichols & Porter LLP
NYC Transit
NYS OPMC

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Bania during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

State of New York, Office of the Attorney General,
Vigorito, Barker, Patterson, Nichols & Porter LLP
NYC Transit
NYS OPMC

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.